Browse All Herpes Market Research Reports
List of reports from Herpes
Displaying 1 to 24 (of 24 records)
| Pages: « Last 1 |
|
Herpes Simplex Infections Global Clinical Trials Review, H1, 2013
Mar 2013 | By - GlobalData
Herpes Simplex Infections Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Herpes Simplex Infections Global Clinical Trials Review, H1, 2013" provides data on the Herpes Simplex Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Simplex Infections. It...
|
$2500 |
|
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013
Mar 2013 | By - GlobalData
linical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013" provides data on the Herpes Zoster (Shingles) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Zoster (Shingles). It includes an overview of the trial...
|
$2500 |
|
Herpes Simplex Infections Pipeline Review, H1 2013
Mar 2013 | By - Global Markets Direct
Herpes Simplex Infections Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Herpes Simplex Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Simplex Infections, complete with latest updates, and special features on late-stage and...
|
$2000 |
|
Genital Herpes Global Clinical Trials Review, H1, 2013
Mar 2013 | By - GlobalData
Genital Herpes Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status...
|
$2500 |
|
Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2013
Mar 2013 | By - GlobalData
Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2013" provides data on the Herpes Labialis (Oral Herpes) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Labialis (Oral Herpes). It includes an...
|
$2500 |
|
Genital Herpes - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Genital Herpes Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Genital Herpes Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Genital Herpes, complete with latest updates, and special features on late-stage and discontinued projects. It also...
|
$2000 |
|
Herpes Zoster (Shingles) - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Herpes Zoster (Shingles) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Herpes Zoster (Shingles) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Zoster (Shingles), complete with latest updates, and special features on late-stage and...
|
$2000 |
|
Herpes Infections - Pipeline Review, H2 2012
Dec 2012 | By - Global Markets Direct
Herpes Infections Pipeline Review, H2 2012
Global Markets Directs, 'Herpes Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
|
$2000 |
|
Herpes Labialis (Oral Herpes) Pipeline Review, H2 2012
Nov 2012 | By - Global Markets Direct
Herpes Labialis (Oral Herpes) Pipeline Review, H2 2012
Summary
Global Markets Directs, 'Herpes Labialis (Oral Herpes) Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Labialis (Oral Herpes), complete with latest updates, and special features on...
|
$2000 |
|
Herpes Simplex Infections - Pipeline Review, H2 2012
Sep 2012 | By - Global Markets Direct
Herpes Simplex Infections Pipeline Review, H2 2012
Global Markets Directs, 'Herpes Simplex Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Simplex Infections, complete with latest updates, and special features on late-stage and discontinued projects....
|
$2000 |
|
Human Herpesvirus 8 (HHV- 8) Infections - Pipeline Review, H2 2012
Sep 2012 | By - Global Markets Direct
Human Herpesvirus 8 (HHV-8) Infections Pipeline Review, H2 2012
Global Markets Directs, 'Human Herpesvirus 8 (HHV-8) Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Human Herpesvirus 8 (HHV-8) Infections, complete with latest updates, and special features on...
|
$2000 |
|
Genital Herpes - Pipeline Review, H2 2012
Aug 2012 | By - Global Markets Direct
Genital Herpes Pipeline Review, H2 2012
Global Markets Directs, 'Genital Herpes Pipeline Review, H2 2012', provides an overview of the Genital Herpes therapeutic pipeline. This report provides information on the therapeutic development for Genital Herpes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
|
$2000 |
|
Herpes Zoster (Shingles) - Pipeline Review, H2 2012
Aug 2012 | By - Global Markets Direct
Herpes Zoster (Shingles) Pipeline Review, H2 2012
Global Markets Directs, 'Herpes Zoster (Shingles) Pipeline Review, H2 2012', provides an overview of the Herpes Zoster (Shingles) therapeutic pipeline. This report provides information on the therapeutic development for Herpes Zoster (Shingles), complete with latest updates, and special features on late-stage and discontinued...
|
$2000 |
|
Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
Apr 2012 | By - GBI Research
GBI Research's report "Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies" finds that the global herpes market is an attractive one, and is expected to witness growth during the forecast period and to provide good opportunities for investors. The expected high growth is attributed to increasing awareness regarding herpes...
|
$3500 |
|
Herpes Simplex Infections Global Clinical Trials Review, H1, 2012
Feb 2012 | By - GlobalData
Herpes Simplex Infections Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, Herpes Simplex Infections Global Clinical Trials Review, H1, 2012" provides data on the Herpes Simplex Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Simplex Infections. It includes an overview of the...
|
$1000 |
|
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2012
Feb 2012 | By - GlobalData
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2012" provides data on the Herpes Zoster (Shingles) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Zoster (Shingles). It includes an overview of the trial...
|
$1000 |
|
Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sep 2011 | By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Herpes Simplex Therapeutics Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global Herpes Simplex Therapeutics market. The report identifies the key trends shaping and driving the global Herpes Simplex Therapeutics market. The report also provides...
|
$3500 |
|
Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jun 2011 | By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Genital Herpes Therapeutics Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Genital Herpes Therapeutics market. The report identifies the key trends shaping and driving the global Genital Herpes Therapeutics market. The report also provides...
|
$2000 |
|
Herpes Zoster Global Clinical Trials Review, Q1, 2011
Apr 2011 | By - GlobalData
Herpes Zoster Global Clinical Trials Review, Q1, 2011 Summary GlobalData's clinical trial report, Herpes Zoster Global Clinical Trials Review, Q1, 2011" provides data on the Herpes Zoster clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Herpes Zoster. It includes an overview of the trial numbers and their recruitment status as per...
|
$1000 |
|
Herpes Simplex Global Clinical Trials Review, Q1, 2011
Apr 2011 | By - GlobalData
GlobalData's clinical trial report, Herpes Simplex Global Clinical Trials Review, Q1, 2011" provides data on the Herpes Simplex clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Herpes Simplex. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the...
|
$1000 |
|
Herpes Labialis Global Clinical Trials Review, Q1, 2011
Apr 2011 | By - GlobalData
GlobalData's clinical trial report, Herpes Labialis Global Clinical Trials Review, Q1, 2011" provides data on the Herpes Labialis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Herpes Labialis. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world,...
|
$1000 |
|
Genital Herpes Global Clinical Trials Review, Q1, 2011
Apr 2011 | By - GlobalData
GlobalData's clinical trial report, Genital Herpes Global Clinical Trials Review, Q1, 2011" provides data on the Genital Herpes clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world,...
|
$1000 |
|
Herpes Zoster - Pipeline Assessment and Market Forecasts to 2017
Apr 2011 | By - GlobalData
GlobalData, the industry analysis specialist, has released its new report, Herpes Zoster Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global herpes zoster market. The report identifies the key trends shaping and driving the global herpes zoster market. The report also provides insights on the prevalent competitive...
|
$2000 |
|
Herpes Simplex - Pipeline Assessment and Market Forecasts to 2017
Jul 2010 | By - GlobalData
GlobalData, the industry analysis specialists new report, Herpes Simplex Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the global herpes simplex market. The report identifies the key trends shaping and driving the global herpes simplex market. The report also provides insight on the prevalent competitive landscape and the emerging...
|
$2000 |
Displaying 1 to 24 (of 24 records)
| Pages: « Last 1 |
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com







